Osteoporosis Trial, Recruiting NCT06947213 Sponsor: Beylikduzu State Hospital Condition: Osteoporosis
Back to Osteoporosis

Osteoporosis Trial, Recruiting

NCT06947213
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Women between the ages of 55 and 75 years old
  • Women who have been diagnosed with osteoporosis based on a bone density scan (DXA) done within the last six months
  • Women in a similar age range who have not been diagnosed with osteoporosis and would participate as healthy comparison participants
  • People who are willing to take part and sign a written consent form

Who may not be able to join:

  • People who do not wish to participate in the study
  • People who have been diagnosed with a psychiatric (mental health) disorder
  • People who have difficulties with memory, thinking, or understanding (cognitive impairment)
  • People who have or have had cancer
  • People who have a hormone-related condition, such as an overactive thyroid or Cushing's syndrome
  • People who are currently taking steroid medications known as glucocorticoids (such as prednisone or cortisone)
  • People who are currently taking medications that affect mood

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Beylikduzu State Hospital
Registry
ClinicalTrials.gov
Start date
20 April 2025
Est. completion
20 May 2025

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

ORTO-11 Scale

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov